IRIS
CARLO STELLA, CARMELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.181
AS - Asia 6.658
EU - Europa 1.766
SA - Sud America 1.166
AF - Africa 310
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 7
Totale 20.102
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.933
SG - Singapore 4.370
BR - Brasile 948
CN - Cina 940
VN - Vietnam 627
FI - Finlandia 368
DE - Germania 257
IE - Irlanda 252
NG - Nigeria 205
HK - Hong Kong 196
IT - Italia 185
FR - Francia 163
CA - Canada 139
GB - Regno Unito 137
IN - India 101
NL - Olanda 77
AR - Argentina 67
MX - Messico 63
BD - Bangladesh 57
TR - Turchia 55
RU - Federazione Russa 50
IQ - Iraq 48
SE - Svezia 43
EC - Ecuador 35
CZ - Repubblica Ceca 31
ES - Italia 30
PK - Pakistan 29
IL - Israele 28
CL - Cile 27
UA - Ucraina 27
PL - Polonia 26
ID - Indonesia 24
BE - Belgio 23
ZA - Sudafrica 22
CO - Colombia 21
PY - Paraguay 21
JP - Giappone 20
UZ - Uzbekistan 19
VE - Venezuela 19
MA - Marocco 18
SA - Arabia Saudita 18
LT - Lituania 16
PH - Filippine 16
AT - Austria 15
EG - Egitto 15
JO - Giordania 13
KE - Kenya 13
PE - Perù 13
NP - Nepal 12
RO - Romania 12
TN - Tunisia 12
UY - Uruguay 12
AU - Australia 10
JM - Giamaica 10
DO - Repubblica Dominicana 9
MY - Malesia 9
AZ - Azerbaigian 8
CR - Costa Rica 8
GR - Grecia 8
IR - Iran 8
A2 - ???statistics.table.value.countryCode.A2??? 7
DZ - Algeria 7
KR - Corea 7
AE - Emirati Arabi Uniti 6
DK - Danimarca 6
AM - Armenia 5
BG - Bulgaria 5
CH - Svizzera 5
ET - Etiopia 5
HN - Honduras 5
LK - Sri Lanka 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
HR - Croazia 4
KZ - Kazakistan 4
LV - Lettonia 4
OM - Oman 4
SN - Senegal 4
GE - Georgia 3
GT - Guatemala 3
HU - Ungheria 3
LB - Libano 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
GA - Gabon 2
KH - Cambogia 2
MD - Moldavia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
Totale 20.081
Salva come PNG Salva come JPEG
Città #
Singapore 1.978
Wilmington 1.310
Chandler 1.266
The Dalles 685
Ashburn 660
Dallas 608
San Jose 509
San Mateo 502
Shanghai 478
Helsinki 362
Ann Arbor 332
Dublin 251
Leawood 243
Boardman 235
Lawrence 225
Princeton 225
Benin City 205
Ho Chi Minh City 189
Hong Kong 188
New York 184
Beijing 155
Hanoi 155
Fairfield 124
Paris 123
Woodbridge 95
Los Angeles 93
Santa Clara 91
São Paulo 77
Amsterdam 74
Toronto 72
London 66
Columbus 63
Seattle 51
Milan 48
Buffalo 43
Da Nang 38
San Diego 32
Rio de Janeiro 31
Munich 28
Montreal 27
Norwalk 27
Phoenix 27
Falls Church 26
Orem 24
Brno 23
Brussels 23
Brasília 22
Chicago 22
Council Bluffs 22
Falkenstein 22
Warsaw 22
Belo Horizonte 20
Naples 20
Brooklyn 19
Haiphong 19
Tashkent 19
Frankfurt am Main 18
Campinas 17
Can Tho 15
Curitiba 15
Dhaka 15
Guayaquil 15
Houston 15
Kocaeli 15
Atlanta 14
Biên Hòa 14
Chennai 14
Stockholm 14
Amman 13
Arizona City 13
Baghdad 13
Mexico City 13
Monmouth Junction 13
Moscow 13
Pune 13
San Francisco 13
Tokyo 13
Boston 12
Gunzenhausen 12
Charlotte 11
Istanbul 11
Johannesburg 11
Nuremberg 11
Vienna 11
Ankara 10
Asunción 10
Denver 10
Hillsboro 10
Montevideo 10
Newark 10
Porto Alegre 10
Redmond 10
Abbiategrasso 9
Guarulhos 9
Lima 9
Manchester 9
Thái Nguyên 9
Baku 8
Hải Dương 8
Mumbai 8
Totale 13.004
Salva come PNG Salva come JPEG
Nome #
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis 172
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®) 145
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH) 144
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogenic stem call transplantation from a HLA identical sibling 141
Primary refractory and early-relapsed Hodgkin's lymphoma : strategies for therapeutic targeting based on the tumour microenvironment 137
American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma 134
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 126
ACQUIRED CYCLIC THROMBOCYTOPENIATHROMBOCYTOSIS WITH PERIODIC DEFECT OF PLATELET-FUNCTION 121
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K delta/gamma Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study 118
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments 115
A case of acute myeloid leukemia, with pseudo-Pelger neutrophils 112
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome 106
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma 105
D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies 105
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation 105
A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNA 99
High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant 99
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 98
Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis 98
Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation 97
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma 97
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 94
Amifostine (WR-2721) selective protection against melphalan genotoxicity 94
Therapeutic relevance of CD34+ cell dose in blood cell transplantation for cancer therapy 93
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection 93
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 93
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes 92
Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice 91
Radioimmunotherapy and secondary leukemia : a case report 90
[Mesenchymal stem cells: biology and clinical applications] 90
Detection of maternal progenitor cells in human umbilical cord blood by single-colony karyotyping 89
Bleomycin genotoxicity and amifostine (WR-2721) cell protection in normal leukocytes vs. K562 tumoral cells 89
Cell therapy: achievements and perspectives 88
Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade? 88
"Overshoot" phenomenon in circulating granulocytic progenitor cell growth during remission of blast crisis in a case of CML 87
Tumor-derived PGD2 and NKp30 –B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 87
Deep learning-based optimization of field geometry for total marrow irradiation delivered with volumetric modulated arc therapy 86
Arachidonic acid induces c-jun gene expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor-a: evidence for a tyrosine-kinase-dependent process 86
AUTOLOGOUS TRANSPLANT FOR CHRONIC MYELOGENOUS LEUKEMIA USING MARROW TREATED EX-VIVO WITH MAFOSFAMIDE 86
Risk of Cancer in Inflammatory Bowel Diseases: Umbrella Review and Reanalysis of Meta-analyses 85
EFFECT OF RECOMBINANT GAMMA-INTERFERON ON THE PROLIFERATIVE ACTIVITY OF CULTURED LEUKEMIC-CELLS 85
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma : a single institution experience 85
Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection 85
New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia 84
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts 84
UMBILICAL-CORD BLOOD AS A SOURCE OF HEMATOPOIETIC STEM-CELLS - FROM RESEARCH TO CLINIC 82
EFFECT OF RECOMBINANT INTERFERON-ALPHA AND INTERFERON-GAMMA ON HUMAN-BONE MARROW DERIVED MEGAKARYOCYTIC PROGENITOR CELLS 82
Microenvironment-related biomarkers and novel targets in classical Hodgkin's lymphoma 82
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia : evidence for premature aging of the myeloid compartment 82
Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies : posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery 82
Detection of minimal residual disease in hematopoietic progenitor cell harvests : lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma 81
Specific histone patterns and acetylase/deacetylase activity at the breakpoint-cluster region of the human MLL gene 81
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia 81
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunological responses in indolent B-cell lymphoma patients with relapsed and measurable disease : a pilot study 80
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients 80
INVITRO MEGAKARYOCYTOPOIESIS IN PATIENTS WITH HIV-RELATED THROMBOCYTOPENIC PURPURA 80
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide 80
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells 79
Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma 79
Stem cells and stem cell transplantation 78
The parallel between CD45 expression and extra-medullary evolution in aggressive myeloma with high serum lactate dehydrogenase 78
Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells 78
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide 78
Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed 78
BIOLOGICAL ASPECTS AND CLINICAL-APPLICATIONS OF LONG-TERM BONE-MARROW CULTURE - A MEETING REPORT 77
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors : mature results of an Italian randomized phase II study 77
Autophagy as a pathogenic mechanism and drug target in lymphoproliferative disorders 77
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases 77
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma 77
ESTABLISHMENT OF 2 EPSTEIN-BARR VIRUS NEGATIVE BURKITT CELL-LINES FROM A PATIENT WITH AIDS AND B-CELL LYMPHOMA 76
BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts 76
Ex vivo manipulation of hematopoietic stem cells for transplantation: The potential role of amifostine 75
Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patients 75
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma 75
Stem cell manipulation: why and how performing peripheral blood progenitor cell purging 75
CD34-POSITIVE CELLS - BIOLOGY AND CLINICAL RELEVANCE 74
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA 74
Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias 74
B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY 74
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice 74
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (mTRAIL) 74
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors. 74
Transforming growth factor beta(3) inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis 74
[Biological screening of immuno-mediated marrow insufficiency by means of the CFU-GM assay] 73
Current role of autologous and allogeneic stem cell transplantation for relapsed and refractory Hodgkin Lymphoma 73
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen) 73
The novel PI3K-ò inhibitor TGR-1202 enhances brentuximab vedotin-induced Hodgkin lymphoma cell death via mitotic arrest. 73
Phase II study of sorafenib in patients with relapsed or refractory lymphoma 73
YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation 73
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial 73
RECOMBINANT GAMMA-INTERFERON INDUCES INVITRO MONOCYTIC DIFFERENTIATION OF BLAST CELLS FROM PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA AND MYELODYSPLASTIC SYNDROMES 72
Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells 72
In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor 72
Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors 72
Forced Expression of RDH10 Gene Retards Growth of HepG2 Cells 72
The anti-HLA-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing NOD/SCID mice 72
INVITRO AND INVIVO EFFECTS OF RECOMBINANT INTERFERON GAMMA ON THE GROWTH OF HEMATOPOIETIC PROGENITOR CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME 72
Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma 72
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts 72
Impact of the Extremities Positioning on the Set-Up Reproducibility for the Total Marrow Irradiation Treatment 71
Totale 8.778
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.521
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021232 0 0 0 0 0 0 0 0 0 0 0 232
2021/20221.277 68 5 19 275 19 20 30 165 130 193 286 67
2022/20233.390 487 102 293 411 326 292 0 310 604 281 236 48
2023/20241.820 139 218 335 41 30 128 67 132 24 36 280 390
2024/20253.375 88 65 33 69 85 328 197 404 531 802 403 370
2025/20268.221 1.247 462 642 743 233 331 2.499 464 467 499 307 327
Totale 20.348